Tianjin Chase Sun Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of December 2023: -0.89%

Tianjin Chase Sun Pharmaceutical Co Ltd (300026) has an Asset Resilience Ratio of -0.89% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥-105.72 Million

≈ $-15.47 Million USD Cash + Short-term Investments

Total Assets

CN¥11.84 Billion

≈ $1.73 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2006–2023)

This chart shows how Tianjin Chase Sun Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Check 300026 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Tianjin Chase Sun Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Tianjin Chase Sun Pharmaceutical Co Ltd market cap and net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥-105.72 Million	-0.89%
Total Liquid Assets	CN¥-105.72 Million	-0.89%

Asset Resilience Insights

Limited Liquidity: Tianjin Chase Sun Pharmaceutical Co Ltd maintains only -0.89% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Tianjin Chase Sun Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Tianjin Chase Sun Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Beijing Sun Novo Pharmaceutical Research Co Ltd SHG:688621	Drug Manufacturers - Specialty & Generic	2.04%
Guizhou Xinbang Pharmaceutical Co Ltd SHE:002390	Drug Manufacturers - Specialty & Generic	0.01%
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	Drug Manufacturers - Specialty & Generic	7.85%
Jw Pharmac KO:001060	Drug Manufacturers - Specialty & Generic	3.65%
Kamada TA:KMDA	Drug Manufacturers - Specialty & Generic	0.00%
Samjin Pharm KO:005500	Drug Manufacturers - Specialty & Generic	0.25%

Annual Asset Resilience Ratio for Tianjin Chase Sun Pharmaceutical Co Ltd (2006–2023)

The table below shows the annual Asset Resilience Ratio data for Tianjin Chase Sun Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	-0.89%	CN¥-105.72 Million ≈ $-15.47 Million	CN¥11.84 Billion ≈ $1.73 Billion	+0.36pp
2022-12-31	-1.25%	CN¥-158.00 Million ≈ $-23.12 Million	CN¥12.63 Billion ≈ $1.85 Billion	+0.33pp
2021-12-31	-1.58%	CN¥-183.67 Million ≈ $-26.88 Million	CN¥11.61 Billion ≈ $1.70 Billion	+0.20pp
2020-12-31	-1.78%	CN¥-181.52 Million ≈ $-26.56 Million	CN¥10.18 Billion ≈ $1.49 Billion	-1.09pp
2019-12-31	-0.69%	CN¥-58.31 Million ≈ $-8.53 Million	CN¥8.43 Billion ≈ $1.23 Billion	-0.28pp
2018-12-31	-0.41%	CN¥-30.99 Million ≈ $-4.53 Million	CN¥7.48 Billion ≈ $1.10 Billion	-0.53pp
2006-12-31	0.12%	CN¥124.36K ≈ $18.20K	CN¥105.62 Million ≈ $15.46 Million	--

pp = percentage points

About Tianjin Chase Sun Pharmaceutical Co Ltd

SHE:300026 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.50 Billion

CN¥10.27 Billion CNY

Market Cap Rank

#7118 Global

#1486 in China

Share Price

CN¥3.42

Change (1 day)

+1.48%

52-Week Range

CN¥2.90 - CN¥4.33

All Time High

CN¥9.11